Quality Management Program
At Aphria, we hold ourselves to the highest standards when it comes to the cultivation and production of medical cannabis. Government and regulatory bodies set the baseline standards to ensure an adequate product. But for us, adequate isn’t good enough.
Through our Quality Management Program, Aphria has always adopted pharmaceutical-grade quality assurance and control, which includes the following:
We do not use chemical pesticides that are not authorized by Health Canada for use on cannabis; we use biological controls. Aphria determines the nutrients and proportions that make up our fertilizer blends which significantly reduces the risk of unwanted chemicals that can be found in ‘pre-mixed’ fertilizers. Once processing is complete, every batch is subjected to full testing against stringent quality specifications set for activity and purity.
We made a strategic investment in a state-of- the-art greenhouse in Leamington, Ontario, which enables us to produce medical cannabis that meets our exacting standards of quality, consistency, and safety.
Good Production Practices
All personnel involved in growing, processing or packaging undergo Good Production Practices training as well as task specific training to ensure consistency, predictability, and safety.
Seed-to- Sale Assurance
We characterize seeds and cuttings and stringently apply ideal growing conditions. Once production begins, we tightly control all aspects of the growing cycle to avoid contamination and ensure predictable results. Only products that meet specifications will be released by the Quality department for sale.
Post-Production Stability Program
In addition to customer feedback systems, our Production and Quality teams work together to effectively match the craft of growing a medicine that has a 1,000-year history of use with all the tools that modern science and technology has to offer to provide a product that is consistent, predictable, and safe for all Canadians.
Considering recent media coverage around pesticide-laden medical marijuana and the impact this is having on Canadians who unknowingly consumed it, Aphria has requested stricter regulations from Health Canada. Please see attached letter for details on our request.
Frequently Asked Questions